Evidence That D-Dimer Levels Predict Subsequent Thromboembolic and Cardiovascular Events in Patients With Atrial Fibrillation During Oral Anticoagulant Therapy
Tài liệu tham khảo
Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007
1996, Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial, Lancet, 348, 633, 10.1016/S0140-6736(96)03487-3
Go, 2003, Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?, JAMA, 290, 2685, 10.1001/jama.290.20.2685
Lip, 1995, Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment, Br Heart J, 73, 527, 10.1136/hrt.73.6.527
Mahe′, 2002, D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillation, Thrombosis Research, 107, 1, 10.1016/S0049-3848(02)00184-6
Nozawa, 2006, D-dimer level influences thromboembolic events in patients with atrial fibrillation, Int J Cardiol, 109, 59, 10.1016/j.ijcard.2005.05.049
Vene, 2003, High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy, Thromb Haemost, 90, 1163, 10.1160/TH03-06-0363
Stein, 2004, D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review, Ann Intern Med, 140, 589, 10.7326/0003-4819-140-8-200404200-00005
Sodeck, 2007, D-dimer in ruling out acute aortic dissection: a systematic review and prospective cohort study, Eur Heart J, 28, 3067, 10.1093/eurheartj/ehm484
Yamaguchi, 2000, Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial, Stroke, 31, 817, 10.1161/01.STR.31.4.817
Ogawa, 2008, Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008), Circ J, 72, 1581